Managing arPEO: Surgery, Safety, and Specialized Care
At a Glance
In arPEO, treatment aims to protect vision and the cornea, not simply lift the eyelids or straighten the eyes. Eyelid surgery may be limited because weak muscles can leave the eye exposed, and POLG-related disease requires avoiding valproate because it can cause life-threatening liver failure.
Because arPEO progresses slowly, the goal of treatment is not to “fix” the eyes to look exactly as they once did, but to maximize your vision and protect the health of your eyes over many years [1]. Management is multidisciplinary, often involving a neuro-ophthalmologist (an eye doctor specializing in nerve/muscle issues), an oculoplastic surgeon, and a neuromuscular specialist [2].
Eyelid Surgery: The Safety Balance
If your drooping eyelids (ptosis) are blocking your vision, surgery can help. However, in arPEO, this is a delicate balance. Surgeons often perform an intentional undercorrection—meaning they don’t lift the lid all the way [1].
The reason for this caution is exposure keratopathy, a condition where the clear front of the eye (the cornea) dries out because the lids no longer close completely, especially during sleep [3].
- The Bell’s Phenomenon: Your doctor will check for this natural reflex where your eyes roll upward when you close them. If this reflex is weak in arPEO, your cornea is at much higher risk of drying out after surgery [4][5].
- Sling Procedures: For patients with very weak lid muscles, surgeons may use a frontalis silicone sling to help you lift your lids using your forehead muscles [4].
Eye Alignment and Comfort
If your eyes are misaligned (strabismus), surgery can sometimes help, but it carries unique risks. In arPEO, the muscles can become fragile or “friable.” Surgeons have reported cases of “pulled-in-two” syndrome, where the muscle is too weak to hold standard surgical tension [6].
For daily comfort and protection, you may use:
- Lubricants: Preservative-free artificial tears during the day and thick ointments at night are the foundation of care [3].
- Scleral Lenses: These are large, specialized contact lenses that create a “reservoir” of moisture over the cornea. They can be life-changing for patients with severe dryness or lids that don’t close [7].
- Ptosis Crutches: These are small attachments for your glasses that physically hold the eyelid up without the need for surgery.
Urgent Eye Care: Seek same-day or urgent eye care for new eye pain, marked redness, light sensitivity, or inability to close the eye, as exposure keratopathy can lead to dangerous corneal ulcers.
Critical Medication Warning: Valproate
If you have a POLG-related form of arPEO, you must avoid the medication Valproate (also called Valproic acid or Depakote) [8]. In people with this specific genetic defect, Valproate can trigger sudden and life-threatening liver failure [9][10]. Ensure this is prominently recorded as a contraindicated/high-risk medication with the gene-specific reason in your medical records (true allergy should be recorded separately). Never stop an existing medication without contacting your prescriber.
Emerging Subtype Treatments
While most arPEO treatment is supportive, research is advancing for specific genetic types:
- TK2 Deficiency: For patients with the TK2 gene mutation, an investigational deoxynucleoside approach using pyrimidine nucleosides has been studied for selected TK2-related mitochondrial DNA-depletion syndromes [11][12].
- RRM2B and Others: Early-stage research is exploring similar nucleoside therapies for other maintenance genes, though these are mostly still in clinical trial phases and not routine [13][14].
Vetting Your Care Team
Since arPEO is rare, it is important to find specialists who have seen it before. Consider asking these questions when meeting a new doctor:
- How many patients with mitochondrial myopathy or PEO have you treated?
- Do you work closely with a geneticist or a mitochondrial medicine specialist to coordinate my care?
- (For surgeons) How do you adjust your surgical technique for someone whose eye muscles are progressively weakening and may be fragile?
- What is your protocol for monitoring my corneal health after surgery?
Focusing on a team that understands these nuances will help ensure your vision remains protected throughout your journey with arPEO [2].
Common questions in this guide
Why might eyelid surgery be intentionally limited in arPEO?
What helps protect my eyes if they do not close completely?
Is strabismus surgery safe for people with arPEO?
Can I take valproate if my arPEO is related to POLG?
Are there treatments targeted to TK2 or RRM2B-related arPEO?
Which specialists should be involved in arPEO care?
Get notified when new evidence is published on Autosomal recessive progressive external ophthalmoplegia.
We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.
References
References (14)
- 1
A review of surgical management of progressive myogenic ptosis.
Park RB, Akella SS, Aakalu VK
Orbit (Amsterdam, Netherlands) 2023; (42(1)):11-24 doi:10.1080/01676830.2022.2122514.
PMID: 36178005 - 2
Ophthalmological signs and sensorimotor evaluation in mitochondrial chronic progressive external ophthalmoplegia: a multidisciplinary prospective study.
Savino G, Giannuzzi F, Cima V, et al.
BMC ophthalmology 2025; (25(1)):520 doi:10.1186/s12886-025-04194-6.
PMID: 41029504 - 3
Surgical management of ptosis in chronic progressive external ophthalmoplegia.
Eshaghi M, Arabi A, Eshaghi S
European journal of ophthalmology 2021; (31(4)):2064-2068 doi:10.1177/1120672120952344.
PMID: 32847396 - 4
Long-term Results of Palpebral Fissure Transfer With No Lower Eyelid Spacer in Chronic Progressive External Ophthalmoplegia.
Karimi N, Kashkouli MB, Tahanian F, et al.
American journal of ophthalmology 2022; (234()):99-107 doi:10.1016/j.ajo.2021.07.027.
PMID: 34339660 - 5
Efficacy of frontalis suspension with silicone rods in ptosis patients with poor Bell's phenomenon.
Shah KP, Mukherjee B
Taiwan journal of ophthalmology 2017; (7(3)):143-148 doi:10.4103/tjo.tjo_36_17.
PMID: 29034153 - 6
Surgical Technique for Pulled in Two Syndrome: Three Cases With Chronic Progressive External Ophthalmoplegia.
Jones AM, Starte J, Dunn H, et al.
Journal of pediatric ophthalmology and strabismus 2017; (54()):e83-e87 doi:10.3928/01913913-20171017-01.
PMID: 29156062 - 7
Chronic Progressive External Ophthalmoplegia (CPEO): Rehabilitation utilizing scleral contact lenses.
Erdinest N, Shemesh N, London N, et al.
American journal of ophthalmology case reports 2025; (39()):102411 doi:10.1016/j.ajoc.2025.102411.
PMID: 41017819 - 8
POLG-related disorders and their neurological manifestations.
Rahman S, Copeland WC
Nature reviews. Neurology 2019; (15(1)):40-52 doi:10.1038/s41582-018-0101-0.
PMID: 30451971 - 9
Distinct Clinical Courses and Shortened Lifespans in Childhood-Onset DNA Polymerase Gamma Deficiency.
Rötig A, Gaignard P, Barcia G, et al.
Neurology. Genetics 2024; (10(4)):e200167 doi:10.1212/NXG.0000000000200167.
PMID: 38975049 - 10
Juvenile/adult-onset POLG-related disease unmasked by valproate-associated fulminant hepatic failure.
Mathavan A, Rathi K, Mundhra LJ, Mathavan A
BMJ case reports 2025; (18(12)) doi:10.1136/bcr-2025-269373.
PMID: 41381198 - 11
Deoxycytidine and Deoxythymidine Treatment for Thymidine Kinase 2 Deficiency.
Lopez-Gomez C, Levy RJ, Sanchez-Quintero MJ, et al.
Annals of neurology 2017; (81(5)):641-652 doi:10.1002/ana.24922.
PMID: 28318037 - 12
Efficacy and safety of pyrimidine nucleos(t)ide therapy in thymidine kinase 2 deficiency.
Hirano M, Garone C, Haas R, et al.
Brain communications 2026; (8(3)):fcag201 doi:10.1093/braincomms/fcag201.
PMID: 42318512 - 13
Investigating the safety and efficacy of deoxycytidine/deoxythymidine in mitochondrial DNA depletion disorders: phase 2 open-label trial.
Berrahmoune S, Dassi C, Pekeles H, et al.
Journal of neurology 2025; (272(4)):307 doi:10.1007/s00415-025-13060-w.
PMID: 40175578 - 14
Deoxynucleoside supplementation ameliorates the disease associated phenotypes in a zebrafish model of RRM2B mtDNA depletion syndrome.
Munro B, Hines D, Mueller JS, Horvath R
Human molecular genetics 2025; (34(11)):967-977 doi:10.1093/hmg/ddaf047.
PMID: 40211788
This page is for informational purposes only and does not constitute medical advice about arPEO surgery or medications. Discuss corneal protection, procedures, and any valproate or other medication concerns with your eye specialist, neuromuscular or mitochondrial specialist, and prescriber; do not stop a medication on your own.